about
Drug therapy for obstructive sleep apnoea in adultsDrug therapy for obstructive sleep apnoea in adultsInvestigation and management of childhood sleep apnoeaDrug treatments for obstructive sleep apnoea.Sleep x 9: an approach to treatment of obstructive sleep apnoea/hypopnoea syndrome including upper airway surgeryOral appliance therapy for obstructive sleep apnea.Respiratory motor activity: influence of neuromodulators and implications for sleep disordered breathing.Central sleep apnea in patients with congestive heart failure.Potential therapeutic targets in obstructive sleep apnoea.Heart failure and sleep disorders.Electrical stimulation therapy improves sleep respiratory parameters in obstructive sleep apnea syndrome: a meta-analysis.Superoxide scavengers improve rat pharyngeal dilator muscle performance.Low-dose theophylline reduces symptoms of acute mountain sickness.Role of endogenous serotonin in modulating genioglossus muscle activity in awake and sleeping rats.The β2 -adrenoceptor agonist terbutaline recovers rat pharyngeal dilator muscle force decline during severe hypoxia.Structural and functional properties of an upper airway dilator muscle in aged obese male rats.Diagnosis and treatment of sleep apnea in heart disease.Mechanisms of breathing instability in patients with obstructive sleep apnea.Sleep-disordered Breathing in Heart Failure.Effect of hypoxia on the hypopnoeic and apnoeic threshold for CO(2) in sleeping humans.A novel inhibitor of the Na+/H+ exchanger type 3 activates the central respiratory CO2 response and lowers the apneic threshold.
P2860
Q24202857-B33D0C77-50E0-4F18-8A66-30A0165D31E6Q24246054-36B41A2A-927B-4A61-9769-3014B15909E8Q26820561-C389FFC5-E691-47A3-854C-D251EB7549CBQ34699195-6A7306A6-3FD1-4926-B8CE-4329FD5B20D5Q35537752-F2F30420-5BD5-475A-9DB8-AA05A34D00EDQ36334814-2A4446E3-E003-4A99-B7AC-4732A7EF8AFDQ36814787-54F05257-0EB4-427F-ADFC-6B2E96B62290Q37231620-DD7ABF34-F25B-42EC-A2DE-2DA772D2629CQ37312912-F0EC3741-6D45-47A9-8542-77003BC8DB7DQ38833163-4BCAC795-7B58-4318-912D-8361C2A2A88DQ43959660-FC662711-FE21-43BF-A9DF-99C99B0C475CQ45918482-A7C42CC5-4035-426D-B745-13B710A99590Q46249026-435E781A-322A-4B80-B5D4-C473A330AAAAQ46601745-006F796C-05BC-4308-98B7-5678F846CB71Q48113838-E64AD645-1E06-492B-80CC-C8CDDE5AF7EEQ48278951-74CB574C-0EF1-47D2-A0C5-76DD943FD15BQ48445413-CD4960B6-F719-4594-8F3C-0D3DB96BE55BQ48457747-F581EDA8-108A-4725-95C0-39E1EA376F5FQ48615154-8EC5D9A9-5316-460D-B5F9-F6E06C1CEBC2Q48685460-05BA9F42-9E32-4B09-A663-15EE1D815648Q48735711-448FA303-892C-4423-93C0-07E27E5020D0
P2860
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Pharmacologic treatment of sleep-disordered breathing.
@en
type
label
Pharmacologic treatment of sleep-disordered breathing.
@en
prefLabel
Pharmacologic treatment of sleep-disordered breathing.
@en
P2860
P1476
Pharmacologic treatment of sleep-disordered breathing.
@en
P2093
Thanakitcharu S
P2860
P304
P356
10.1164/AJRCCM.158.3.9802019
P407
P577
1998-09-01T00:00:00Z